Oral Oncology
Volume 38, Issue 7 , Pages 699-705 , October 2002

Molecular characterization of angiogenic properties of human oral squamous cell carcinoma cells

  • Yi-Ju Chen

      Affiliations

    • Institute of Molecular Medicine, National Cheng Kung University Medical College, 1, University Road, Tainan 70101, Taiwan, ROC
    • ,
  • Ying-Tai Jin

      Affiliations

    • Department of Pathology, National Cheng Kung University Medical College, Tainan 70101, Taiwan, ROC
    • ,
  • Dar-Bin Shieh

      Affiliations

    • Department of Medicine, National Cheng Kung University Medical College, Tainan 70101, Taiwan, ROC
    • ,
  • Sen-Tien Tsai

      Affiliations

    • Department of Otolaryngology, National Cheng Kung University Medical College, Tainan 70101, Taiwan, ROC
    • ,
  • Li-Wha Wu

      Affiliations

    • Institute of Molecular Medicine, National Cheng Kung University Medical College, 1, University Road, Tainan 70101, Taiwan, ROC
    • Corresponding Author InformationCorresponding author

Received 22 October 2001 ,Accepted 18 December 2001.

References 

  1. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking, and alcohol consumption related to oral cancer in Taiwan. J. Oral Pathol. Med. 1995;24:450–453
  2. Jin YT, Tsai ST, Wong TY, Chen FF, Chen RMY. Studies on promoting activity of Taiwan betel quid ingredients in hamster buccal pouch carcinogenesis. Eur. J. Cancer. 1996;32B:343–346
  3. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol. 1999;35:173–179
  4. Folkman J. What is the evidence that tumors are angiogenesis-dependent. J. Natl. Cancer Inst. 1990;82:4–6
  5. Gasparini GW, Maluta S, Pozza F, Boracchi P, Messetti M, Testolin A, et al. Intratumoral microvessel density and p53: correlation with metastasis in head-and-neck squamous cell carcinoma. Int. J. Cancer. 1993;55:739–744
  6. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igrashi M, Yamamoto A, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvment of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology. 1998;27:1554–1562
  7. Maeda T, Matsumura S, Hiranuma H, Jikko A, Furukawa S, Ishida T, et al. Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status. J. Clin. Pathol. 1998;51:771–775
  8. Bussolino F, Mantovani A, Persico G. Molecular mechanism of blood vessel formation. TIBS. 1997;22:251–256
  9. Eisma RJ, Spiro JD, Kreutzer DL. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck carcinoma. Laryngoscope. 1999;109:687–693
  10. Shemirani B, Crowe DL. Head and neck squamous cell carcinoma lines produce biologically active angiogenic factors. Oral Oncol. 2000;36:61–66
  11. Bouck N, Stellmach V, Hsu SC. How tumors become angiogenic. Advances in Cancer Res. 1996;69:135–174
  12. Ferrara N, Davis-Symth T. The biology of vascular endothelial growth factor. Endocrin. Rev. 1997;18:4–25
  13. Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M. Vascular endothelial growth facotr is a marker of tumor invasion and metastasis in squamous cell carcinoma of the head and neck. Clin. Cancer Res. 1999;5:775–782
  14. Yano T, Tanikawa S, Fujie T, Masutani M, Horie T. Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer. Eur J Cancer. 2000;36:601–609
  15. Caamano J, Zhang SY, Rosvold EA, Bauer B, Klein-Szanto AJ. p53 alteration in human squamous cell carcinoma and carcinoma cell lines. Am. J. Pathol. 1993;142:1131–1139
  16. Min BM, Baek JH, Shin KH, Gujuluva CN, Cherrick HM, Park NH. Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral sqamous cell carcinoma cell lines. Eur. J. Cancer B. Oral Oncol. 1994;30B:338–345
  17. Bouvet M, Ellis LM, Nishizaki M, Fujiwara T, Liu W, Bucana CD, et al. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res. 1998;58:2288–2292
  18. Wong DY, Chang K-W, Chen C-F, Chang RC. Characterization of two new cell lines derived from oral cavity human sqamous cell carcinoma-OC1 and OC2. J. Oral Maxillofac. Surg. 1990;48:385–390
  19. Oda D, Watson E. Human oral epithelial cell culture in improved conditions for reproducible culture in serum-free medium. In Vitro Cell. Dev. Biol. 1990;26:589–598
  20. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 1973;52:2745–2756
  21. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial grwoth factor is a potent tumor angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845–848
  22. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 1996;77:858–863
  23. Kim MS, Li S-L, Bertolami CN, Cherrick HM, Park N-H. State of p53, Rb, DCC tumor suppressor genes in human oral cancer cell lines. Anticancer Res. 1993;13:1405–1414
  24. Hollstein M, Sideransky D, Vogelstein B, Harris CC. p53 mutations in human cancer. Science. 1991;253:49–53
  25. Ogura H, Yoshinouchi M, Kudo T, Imura M, Fujiwara T, Yabe Y. Human papillomavirus type 18 DNA in so-called HEP-2, KB and FL cells-further evidence that these cells are HeLa cell derivatives. Cell. Mol. Biol. 1993;39:463–467
  26. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature. 1993;362:857–860
  27. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. U.S.A. 1986;83:7297–7301
  28. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129–1136
  29. Momand J, Jung D, Wilczynski S, Niland J. The MDM2 gene amplification database. Nucleic Acids Res. 1998;26:3453–3459
  30. Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G. The p53/p63/p73 family of transcription factors:overlapping and distinct functions. J. Cell Sci. 2000;113:1661–1670

PII: S1368-8375(02)00004-0

Oral Oncology
Volume 38, Issue 7 , Pages 699-705 , October 2002

Article Tools

* Image Usage & Resolution